View Financial HealthPlant Advanced Technologies 配当と自社株買い配当金 基準チェック /06Plant Advanced Technologies配当金を支払った記録がありません。主要情報n/a配当利回りn/aバイバック利回り総株主利回りn/a将来の配当利回りn/a配当成長n/a次回配当支払日n/a配当落ち日n/a一株当たり配当金n/a配当性向n/a最近の配当と自社株買いの更新更新なしすべての更新を表示Recent updatesValuation Update With 7 Day Price Move • Jul 19Investor sentiment improves as stock rises 16%After last week's 16% share price gain to €6.45, the stock trades at a trailing P/E ratio of 13.2x. Average trailing P/E is 16x in the Biotechs industry in Europe. Total loss to shareholders of 25% over the past year.Valuation Update With 7 Day Price Move • Jun 25Investor sentiment deteriorates as stock falls 24%After last week's 24% share price decline to €4.66, the stock trades at a trailing P/E ratio of 10.2x. Average trailing P/E is 16x in the Biotechs industry in Europe. Total loss to shareholders of 46% over the past year.New Risk • May 31New minor risk - Profit margin trendThe company's profit margins are lower than last year and have reduced by more than 30%. Net profit margin: 29% Last year net profit margin: 42% This is considered a minor risk. A large drop in profit margin could indicate the company does not have strong competitive advantages or it is yet to establish itself and its core business. Even if it is a well established business, this may make it a much riskier investment than one that has a combination of proven competitive advantages and a stable or growing profit margin. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (16% average weekly change). Market cap is less than US$10m (€7.74m market cap, or US$9.03m). Minor Risks Profit margins are more than 30% lower than last year (29% net profit margin). Revenue is less than US$5m (€2.0m revenue, or US$2.3m).お知らせ • May 25Plant Advanced Technologies SA, Annual General Meeting, Jun 30, 2026Plant Advanced Technologies SA, Annual General Meeting, Jun 30, 2026. Location: 2 bis de la rue des chantons, laronxe FranceBoard Change • May 20No independent directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 9 experienced directors. No highly experienced directors. No independent directors (9 non-independent directors). Representative Director Michael Donabedian was the last director to join the board, commencing their role in 2020. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.お知らせ • May 27Plant Advanced Technologies SA, Annual General Meeting, Jun 28, 2024Plant Advanced Technologies SA, Annual General Meeting, Jun 28, 2024. Location: amphitheatre cuenot de l ensaia de l universite, de lorraine, 2 avenue de la foret de haye, vandoeuvre les nancy FranceNew Risk • Apr 30New major risk - Financial data availabilityThe company's latest financial reports are more than a year old. Last reported fiscal period ended December 2022. This is considered a major risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. In the worst case scenario, it may be facing other major going concern issues jeopardizing its viability as a listed company. Currently, the following risks have been identified for the company: Major Risks Latest financial reports are more than 1 year old (reported December 2022 fiscal period end). Shares are highly illiquid. Minor Risks Revenue is less than US$5m (€2.3m revenue, or US$2.5m). Market cap is less than US$100m (€11.5m market cap, or US$12.4m).Board Change • Apr 16No independent directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 10 experienced directors. No highly experienced directors. No independent directors (10 non-independent directors). Representative Director Michael Donabedian was the last director to join the board, commencing their role in 2020. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.決済の安定と成長配当データの取得安定した配当: 9FQの 1 株当たり配当が過去に安定していたかどうかを判断するにはデータが不十分です。増加する配当: 9FQの配当金が増加しているかどうかを判断するにはデータが不十分です。配当利回り対市場Plant Advanced Technologies 配当利回り対市場9FQ 配当利回りは市場と比べてどうか？セグメント配当利回り会社 (9FQ)n/a市場下位25% (DE)1.6%市場トップ25% (DE)4.7%業界平均 (Biotechs)2.3%アナリスト予想 (9FQ) (最長3年)n/a注目すべき配当: 9FQは最近配当金を報告していないため、配当金支払者の下位 25% に対して同社の配当利回りを評価することはできません。高配当: 9FQは最近配当金を報告していないため、配当金支払者の上位 25% に対して同社の配当利回りを評価することはできません。株主への利益配当収益カバレッジ: 9FQの 配当性向 を計算して配当金の支払いが利益で賄われているかどうかを判断するにはデータが不十分です。株主配当金キャッシュフローカバレッジ: 9FQが配当金を報告していないため、配当金の持続可能性を計算できません。高配当企業の発掘7D1Y7D1Y7D1YDE 市場の強力な配当支払い企業。View Management企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/07/25 12:36終値2026/07/20 00:00収益2025/12/31年間収益2025/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレークこのレポートを生成するために使用した分析モデルの詳細は、当社のGitHubページでご覧いただけます。また、レポートの活用方法に関するガイドやYouTubeのチュートリアルも用意しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Plant Advanced Technologies SA 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。3 アナリスト機関Charles-Louis PlanadeTPICAP MidcapFlorent Thy-TineTPICAP MidcapClaire DerayTPICAP Midcap
Valuation Update With 7 Day Price Move • Jul 19Investor sentiment improves as stock rises 16%After last week's 16% share price gain to €6.45, the stock trades at a trailing P/E ratio of 13.2x. Average trailing P/E is 16x in the Biotechs industry in Europe. Total loss to shareholders of 25% over the past year.
Valuation Update With 7 Day Price Move • Jun 25Investor sentiment deteriorates as stock falls 24%After last week's 24% share price decline to €4.66, the stock trades at a trailing P/E ratio of 10.2x. Average trailing P/E is 16x in the Biotechs industry in Europe. Total loss to shareholders of 46% over the past year.
New Risk • May 31New minor risk - Profit margin trendThe company's profit margins are lower than last year and have reduced by more than 30%. Net profit margin: 29% Last year net profit margin: 42% This is considered a minor risk. A large drop in profit margin could indicate the company does not have strong competitive advantages or it is yet to establish itself and its core business. Even if it is a well established business, this may make it a much riskier investment than one that has a combination of proven competitive advantages and a stable or growing profit margin. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (16% average weekly change). Market cap is less than US$10m (€7.74m market cap, or US$9.03m). Minor Risks Profit margins are more than 30% lower than last year (29% net profit margin). Revenue is less than US$5m (€2.0m revenue, or US$2.3m).
お知らせ • May 25Plant Advanced Technologies SA, Annual General Meeting, Jun 30, 2026Plant Advanced Technologies SA, Annual General Meeting, Jun 30, 2026. Location: 2 bis de la rue des chantons, laronxe France
Board Change • May 20No independent directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 9 experienced directors. No highly experienced directors. No independent directors (9 non-independent directors). Representative Director Michael Donabedian was the last director to join the board, commencing their role in 2020. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.
お知らせ • May 27Plant Advanced Technologies SA, Annual General Meeting, Jun 28, 2024Plant Advanced Technologies SA, Annual General Meeting, Jun 28, 2024. Location: amphitheatre cuenot de l ensaia de l universite, de lorraine, 2 avenue de la foret de haye, vandoeuvre les nancy France
New Risk • Apr 30New major risk - Financial data availabilityThe company's latest financial reports are more than a year old. Last reported fiscal period ended December 2022. This is considered a major risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. In the worst case scenario, it may be facing other major going concern issues jeopardizing its viability as a listed company. Currently, the following risks have been identified for the company: Major Risks Latest financial reports are more than 1 year old (reported December 2022 fiscal period end). Shares are highly illiquid. Minor Risks Revenue is less than US$5m (€2.3m revenue, or US$2.5m). Market cap is less than US$100m (€11.5m market cap, or US$12.4m).
Board Change • Apr 16No independent directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 10 experienced directors. No highly experienced directors. No independent directors (10 non-independent directors). Representative Director Michael Donabedian was the last director to join the board, commencing their role in 2020. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.